PETV vs. GCTK, BTCY, OSA, VAPO, VVOS, PSTV, GBS, NXGL, NURO, and MBOT
Should you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include GlucoTrack (GCTK), Biotricity (BTCY), ProSomnus (OSA), Vapotherm (VAPO), Vivos Therapeutics (VVOS), Plus Therapeutics (PSTV), GBS (GBS), NEXGEL (NXGL), NeuroMetrix (NURO), and Microbot Medical (MBOT). These companies are all part of the "surgical & medical instruments" industry.
PetVivo (NASDAQ:PETV) and GlucoTrack (NASDAQ:GCTK) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability, dividends and community ranking.
PetVivo has a beta of 2.08, indicating that its share price is 108% more volatile than the S&P 500. Comparatively, GlucoTrack has a beta of 0.29, indicating that its share price is 71% less volatile than the S&P 500.
In the previous week, GlucoTrack had 8 more articles in the media than PetVivo. MarketBeat recorded 9 mentions for GlucoTrack and 1 mentions for PetVivo. GlucoTrack's average media sentiment score of 0.59 beat PetVivo's score of 0.03 indicating that GlucoTrack is being referred to more favorably in the news media.
24.6% of PetVivo shares are held by institutional investors. Comparatively, 10.9% of GlucoTrack shares are held by institutional investors. 20.1% of PetVivo shares are held by insiders. Comparatively, 17.7% of GlucoTrack shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
GlucoTrack has a net margin of 0.00% compared to PetVivo's net margin of -1,016.64%. GlucoTrack's return on equity of -172.38% beat PetVivo's return on equity.
PetVivo and GlucoTrack both received 0 outperform votes by MarketBeat users.
GlucoTrack has lower revenue, but higher earnings than PetVivo. GlucoTrack is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.
Summary
GlucoTrack beats PetVivo on 7 of the 12 factors compared between the two stocks.
Get PetVivo News Delivered to You Automatically
Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
